BayWa's Fate Hinges on April Cash Infusion and Bank Talks

German group BayWa faces a critical April 30 deadline to secure €107M from a sale and extend bank agreements, or its entire €4B restructuring plan collapses.

The clock is ticking for German agricultural trading group BayWa. The company’s entire restructuring plan faces a critical test at the end of April, with its fate resting on securing a cash payment and convincing two key banks to stay on board.

Financial and Legal Timelines Converge

By April 30, BayWa must collect approximately EUR 107 million from the sale of its agricultural subsidiary Cefetra. This sum comprises EUR 45 million in direct proceeds and EUR 62 million from the repayment of shareholder loans. This cash is not primarily for debt repayment but serves as crucial leverage in negotiations with its core banks, DZ Bank and HVB. Both institutions must agree to extend a standstill agreement until autumn 2026.

Should the banks refuse, the StaRUG restructuring plan finalized in May 2025 loses its legal foundation. While the Cefetra proceeds are intended to reduce group bank debt by over EUR 600 million, this provides only marginal structural relief. The total restructuring target remains a daunting EUR 4 billion.

A Massive Funding Gap and Operational Cuts

So far, only EUR 1.3 billion of that target is secured, leaving a massive EUR 2.7 billion shortfall. Operationally, a severe cost-cutting program is underway, with 1,300 jobs to be cut and 26 branches permanently closed by 2027. Management has withdrawn its annual forecast for 2026 and lowered its adjusted EBITDA target for 2027 to around EUR 140 million.

The next major asset sale is the planned divestment of New Zealand fruit trading subsidiary T&G Global. BayWa mandated Goldman Sachs in March 2026 for a sale expected to yield roughly EUR 300 million. However, the process is complicated by minority shareholder Joy Wing Mau, which holds nearly 20% of T&G Global.

Core Valuation Problem and Legal Woes

The restructuring’s core problem stems from a failed earlier plan. An intended partial sale of the renewable energy unit BayWa r.e.—51% for up to EUR 1.7 billion—collapsed after the US cut renewable energy subsidies in early 2025. Consequently, BayWa now expects the unit to achieve EBITDA of EUR 150 million only by 2030, a drop of roughly 35% from the previously projected EUR 230 million for 2028, severely impacting the subsidiary's valuation.

Legal pressures are mounting alongside financial ones. Munich I public prosecutors are investigating former CEOs for alleged breach of trust, focusing on the 2023 financial statements. The presumption of innocence applies to all accused. Financial regulator BaFin has already censured the company for failing to disclose a billion-euro loan, and a law firm is preparing shareholder damage claims based on this. BayWa is also ending its relationship with auditor PwC after 2025 and is examining potential liability claims against the firm.

Investors Left in the Dark

For shareholders, the situation is characterized by a lack of clarity. The audited consolidated financial statements for 2025 are not expected until the fourth quarter of 2026 at the earliest, delayed by ongoing restructuring and the pending revaluation of BayWa r.e. This leaves investors without certified numbers for an extended period.

Boardroom stability has also suffered, with three supervisory board members resigning. The threshold for transactions requiring board approval has been lowered from EUR 200 million to EUR 50 million.

On the stock market, the shares trade around EUR 14.50, more than 14% below their 200-day moving average. Despite a recent daily gain of nearly 4%, the stock has lost over 13% since the start of the year. Two events will dictate its future trajectory: the crucial bank agreement and the delayed audited financials, both anticipated no earlier than Q4 2026. Until then, the company’s survival remains on a knife-edge.